middle.news
Artrya Advances US Market Bid with FDA Filing for AI Coronary Plaque Module
8:57am on Monday 16th of June, 2025 AEST
•
Healthcare
Read Story
Artrya Advances US Market Bid with FDA Filing for AI Coronary Plaque Module
8:57am on Monday 16th of June, 2025 AEST
Key Points
FDA 510(k) submission filed for Salix® Coronary Plaque module
Module enables near real-time detection of high-risk coronary plaque
Integration planned with FDA-cleared Salix® Coronary Anatomy platform
Qualifies for US reimbursement at US$950 per assessment upon clearance
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Artrya (ASX:AYA)
OPEN ARTICLE